Structural studies on bioactive compounds. 40.1 synthesis and biological properties of fluoro-, methoxyl-, and amino-substituted 3-phenyl-4H-1-benzopyran-4-ones and a comparison of their antitumor activities with the activities of related 2-phenylbenzothiazoles

Journal of Medicinal Chemistry

Volumn 49, Issue 13, 2006, Pages 3973-3981

  Vasselin, David A ^a   Westwell, Andrew D ^b   Matthews, Charles S ^a   Bradshaw, Tracey D ^a   Stevens, Malcolm F G ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 PHENYLBENZOTHIAZOLE DERIVATIVE; 3 PHENYL 4H 1 BENZOPYRAN 4 ONE DERIVATIVE; BENZOPYRAN DERIVATIVE; BENZOTHIAZOLE DERIVATIVE; FLAVONE DERIVATIVE; GENISTEIN; ISOFLAVONE DERIVATIVE; QUERCETIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HCT116; CELL STRAIN HT29; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME ACTIVATION; ENZYME INDUCTION; HUMAN; HUMAN CELL; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHROMONES; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES;

EID: 33745642100     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm060359j     Document Type: Article

References (36)

1. Part 39: Richardson, M. L.; Croughton, K. A.; Matthews, C. S.; Stevens, M. F. G. Structural studies on bioactive compounds. 39. Biological consequences of the structural modification of DHFR-inhibitory 2,4-diamino-6-(4-substituted- benzylamino-3-nitrophenyl)-6-ethylpyrimidines ('benzoprims'). J. Med. Chem. 2004, 47, 4105-4108.
2. Harborne, J. B.; Williams, C. A. Advances in flavanoid research since 1992. Phytochemistry 2000, 55, 481-504.
3. Middleton, E.; Kandaswami, C.; Theoharides, T. C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol. Rev. 2000, 52, 673-751.
4. Birt, D. F.; Hendrich, S.; Wang, W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol. Ther. 2001, 90, 157-177.
5. Daskiewicz, J.-P.; Depeint, F.; Vionery, L.; Bayet, C.; Comte-Sarrazin, G.; Comte, G.; Gee, J. M.; Johnson, I. T.; Ndjoko, K.; Hostettmann, K.; Barron, D. Effects of flavonoids on cell proliferation and caspase activation in a human colonic cell line HT29: An SAR study. J. Med. Chem. 2005, 48, 2790-2804.
6. Li, Y. W.; Ahmed, F.; Ali, S.; Philip, P. A.; Kucuk, O.; Sarkar, F. H. Inactivation of nuclear factor κB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res. 2005, 65, 6934-6942.
7. Van tyghem, S. A.; Wilson, S. M.; Postenka, C. O.; Al-Katib, W.; Tuck, A. B.; Chambers, A. F. Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model. Cancer Res. 2005, 65, 3396-3403.
8. Ju, Y. H.; Doerge, D. R.; Allred, K. F.; Allred, C. D.; Helferich, W. G. Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) tumors in a dose-dependent manner. Cancer Res. 2002, 62, 2474-2477.
9. Lu, L. J. W.; Anderson, K. E.; Grady, J. J.; Kohen, F.; Nagamani, M. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res. 2000, 60, 4112-4121.
10. Stevens, M. F. G.; McCall, C. J.; Lelieveld, P.; Alexander, P.; Richter, A.; Davies, D. E. Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin. J. Med. Chem. 1994, 37, 1689-1695.
11. Loaiza-Pérez, A. L.; Trapani, V.; Hose, C.; Singh, S. S.; Trepel, J.; Stevens, M. F. G.; Bradshaw, T. D.; Sausville, E. A. The aryl hydrocarbon receptor mediates sensitivity of MCF-7 breast cancer cells to the antitumor agent 2-(4-amino-3-methylphenyl)benzothiazole. Mol. Pharmacol. 2002, 61, 13-19.
12. Trapani, V.; Patel, V.; Ciolino, H. P.; Yeh, G. C.; Hose, C.; Trepel, J. B.; Stevens, M. F. G.; Sausville, E. A.; Loaiza-Pérez, A. L. DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5- fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells. Br. J. Cancer 2003, 88, 599-605.
13. Leong, C. O.; Suggitt, M.; Swaine, D. J.; Bibby, M. C.; Stevens, M. F. G.; Bradshaw, T. D. In vitro, in vivo, and in silico analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoles. Mol. Cancer Ther. 2004, 3, 1565-1575.
14. Fichtner, I.; Monks, A.; Hose, C.; Stevens, M. F. G.; Bradshaw, T. D. The experimental antitumor agents Phortress and doxorubicin are equiactive against human-derived breast carcinoma xenograft models. Breast Cancer Res. Treat. 2004, 87, 97-107.
15. Bradshaw, T. D.; Westwell, A. D. The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate. Curr. Med. Chem. 2004, 11, 1241-1253.
16. Mortimer, C. G.; Wells, G.; Crochard, J.-P.; Stone, E. L.; Bradshaw, T. D.; Stevens, M. F. G.; Westwell, A. D. Antitumor benzothiazoles. 26. 2-(3,4-Dimethoxyphenyl)-5-fluorobenzothiazole (GW 610; NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon and breast cancer cell lines. J. Med. Chem. 2006, 49, 179-185.
17. Yokoe, I.; Sugita, Y.; Shirataki, Y. Facile synthesis of isoflavones by the cross-coupling reaction of 3-iodochromone with arylboronic acids. Chem. Pharm. Bull. 1989, 37, 529-530.
18. Valoti, E.; Pallavicini, M.; Villa, L.; Pezzetta, D. Synthesis of homochiral 5- and 8-substituted 2-[((2-(2,6-dimethoxyphenoxy)ethyl)-amino) methyl]-1,4-benzodioxanes and electrophoretic determination of their enantiomeric excess. J. Org. Chem. 2001, 66, 1018-1025.
19. Jain, A. C.; Bambah, P. K. Synthesis of naturally occurring pratensein and 6,8-di-C-prenylpratensein. Indian J. Chem. 1987, 26, 488-490.
20. Gammill, R. B. A new efficient synthesis of 3-halogenated 4H-1-benzopyran-4-ones. Synthesis 1979, 901-903.
21. Murata, M.; Watanabe, S.; Masuda, Y. Novel palladium(0)-catalysed coupling reactions of dialkoxyborane with aryl halides: convenient synthetic route to arylboronates. J. Org. Chem. 1997, 62, 6458-6459.
22. Murata, M.; Oyama, T.; Watanabe, S.; Masuda, Y. Palladium-catalysed borylation of aryl halides or inflates with dialkoxyborane: a novel and facile synthetic route to arylboronates. J. Org. Chem. 2000, 65, 164-168.
23. Mitchell, T. M. Palladium-catalysed reactions of organotin compounds. Synthesis 1992, 803-815.
24. Evans, P. A.; Nelson, J. D.; Mannanagan, T. Preparation and palladium mediated cross-coupling reactions of cis-2,3-disubstituted 5-halodihydropyran-4- ones. Synlett 1997, 968-970.
25. Boyd, M. R.; Paull, K. D. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev. Res. 1995, 34, 91-104.
26. Weinstein, J. N.; Myers, T. G.; O'Connor, P. M.; Friend, S. H.; Fornace, A. J.; Kohn, K. W.; Fojo, T.; Bates, S. E.; Rubinstein, L. V.; Anderson, N. L.; Buolamwini, J. K.; van Osdol, W. W.; Monks, A. P.; Scudiero, D. A.; Sausville, E. A.; Zaharevitz, D. W.; Bunow, B.; Viswanadhan, V. N.; Johnson, G. S.; Wittes, R. E.; Paull, K. D. An information-intensive approach to the molecular pharmacology of cancer. Science 1997, 275, 343-349.
27. Chua, M. S.; Kashiyama, E.; Bradshaw, T. D.; Stinson, S. F.; Brantley, E.; Sausville, E. A.; Stevens, M. F. G. Role of CYP1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells. Cancer Res. 2000, 60, 5196-5203.
28. Hutchinson, I.; Chua, M.-S.; Browne, H. L.; Trapani, V.; Bradshaw, T. D.; Westwell, A. D.; Stevens, M. F. G. Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles. J. Med. Chem. 2001, 42, 4172-4184.
29. Kashiyama, E.; Hutchinson, I.; Chua, M.-S.; Stinson, S. F.; Phillips, L. R.; Kaur, G.; Sausville, E. A.; Bradshaw, T. D.; Westwell, A. D.; Stevens, M. F. G. Antitumor benzothiazoles. 8. Synthesis, metabolic formation and biological properties of the C- and N-oxidation products of antitumor 2-(4-aminophenyl) benzothiazoles. J. Med. Chem. 1999, 42, 4172-4184.
30. Akama, T.; Ishida, H.; Kimura, U.; Gomi, K.; Saito, H. Structure-activity relationships of the 7-substituents of 5,4′-diamino-6,8,3- trifluoroflavone, a potent antitumor agent. J. Med. Chem. 1998, 41, 2056-2067.
31. Weaver, R. J.; Thompson, S.; Smith, G.; Dickins, M.; Elcombe, C. R.; Mayer, R. T.; Burke, M. D. A comparative study of constituitive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (macaca fascicularis), human, mouse, rat and hamster liver microsomes. Biochem. Pharmacol. 1994, 47, 763-773.
32. Wilson, C. L.; Thomsen, J.; Hoivik, D. J.; Wormke, M. T.; Stanker, L.; Holtzapple, C.; Safe, S. H. Aryl hydrocarbon (Ah) nonresponsiveness in estrogen-receptor negative MDA-MB-231 cells is associated with expression of a variant Arnt protein. Arch. Biochem. Biophys. 1997, 346, 65-73.
33. Fretland, A. J.; Safe, S.; Hankinson, O. Lack of antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin's (TCDDs) induction of cytochrome P4501A1 (CYP1A1) by the putative selective aryl hydrocarbon receptor modulator 6-alkyl-1,3,8-trichlorodibenzofuran (6-MCDF) in the mouse hepatoma cell line Hepa-1c1c7. Chem.-Biol. Interact. 2004, 150, 161-170.
34. Kanna, M. S.; Singh, O. M.; Gag, C. P.; Kapoor, R. P. Oxidation of flavanones using thallium(III) salts: a new route for the synthesis of flavones and isoflavones. J. Chem. Soc., Perkin Trans. 1 1992, 2565-2568.
35. Hoshino, Y.; Miyaura, N.; Suzuki, A. A novel synthesis of isoflavones by the palladium-catalysed cross-coupling reaction of 3-bromochromones with arylboronic acids or its esters. Bull. Chem. Soc. Jpn. 1988, 61, 3008-3010.
36. Bradford, M. M. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.